- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05993676
MeT4VeT: Mental Health Toolkit for Military Veterans Trial
A Feasibility Trial of a Smartphone App to Support the Mental Health of UK Armed Forces Veterans (MeT4VeT)
The proposed research involves the running of a feasibility trial to assess a smart phone app designed to support military veterans (as they transition out of the Armed Forces) experiencing mental health difficulties to monitor and manage their mental health, encouraging them to seek formal mental healthcare services if required. The trial will compare participants who are provided with the 'full' app (case group) with participants who receive a 'signposting only' feature free smartphone app, receiving the 'full' app 3months later once the research trial is over (control group).
The feasibility trial has two core aims:
- To provide initial assessment of the practicality of testing the app Running of the feasibility trial will provide key information on the practical delivery of the app and measurement processes; enable an estimation of recruitment and retention of participants; as well as trialling a series of outcome measures. All participants taking part in the trial will be asked to complete a short (20minute) in app survey at three time points: baseline; baseline plus 1month; baseline plus 3months. This questionnaire will collect demographic information and employ a number of well-being and quality of life measures.
- To provide initial feedback on the app The trial will qualitatively evaluate how those in the case group use the 'full' app (via collection of app usage data over a 1month trial period) and how easy to interact with, and potentially helpful, they consider the app might be (via a short 30minute telephone interview at the end of the 1month app trial period).
If the trial indicates that the app is acceptable and feasible then a full randomized control trial (subject to funding) will be run to assess the effectiveness of the app in supporting mental health. If proven acceptable then the app would be made freely available to all.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In line with the Medical Research Council Complex Intervention Framework (Medical Research Council) the feasibility stage of developing an intervention is focused on three areas to assess the practical aspects of testing an intervention including:
- Testing procedures (technical app delivery; measurement processes)
- Estimating recruitment and retention (number of eligible/ interested participants; drop-out rates)
- Determining sample size (testing main outcome measures to determine appropriate sample size for a later randomised control trial)
In addition to this, the feasibility trial will provide feedback from participants on their reactions to the app including:
- Actual use of the app
- Satisfaction with the app
- How appropriate they believe the app to be
- Intent for continued use
This toolkit will provide those who participate in the research with an additional support tool which may help them to manage their own mental health during a potentially challenging period (as they transition out of the Armed Forces) and help them to identify a need for more formal support if required.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, SE5 9RJ
- King's College London
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Males
- Own a smartphone
- Served at least 2 years in the UK Armed Forces
- Left the UK Armed Forces within the last 2 years
- Not currently undertaking formal mental health treatment (mental health therapy by a medical professional)
- Indicate a degree of mental health distress (assessed via a score of two or more on the GHQ-12
Exclusion Criteria:
- Those who display current suicidal ideation / self-harm
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: Control
The control group received an app containing only signposting information about a range of statutory and third sector organisations that focused on veterans' mental health.
|
The control/ sham comparator arm of the Mental Health Toolkit for Veterans (MeT4VeT) smart phone app contains only signposting information around support services available to military veterans
|
|
Active Comparator: Intervention
The intervention group will receive a 'full' version of the app over the 1month trial period. The app consists of five core elements:
|
The Mental Health Toolkit for Veterans (MeT4VeT) smart phone app has been developed through careful and close collaboration with military veterans and key providers of veterans' mental healthcare services. The aim of this app is to provide both a degree of education to support military veterans' understanding of mental health and foster self-recognition and management of mental health symptoms whilst also encouraging those who need it to seek more formal support. The elements of the app have been chosen for inclusion as they represent the intersection between:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recruitment and retention: Number of interested participants
Time Frame: 5month recruitment period
|
Calculate the total number of participants contacting the study team to express an interest in taking part in the study.
|
5month recruitment period
|
|
Recruitment and retention: Number of eligible participants
Time Frame: 5month recruitment period
|
Calculate the total number of participants contacting the study team to express an interest in taking part in the study who are eligible to take part.
Calculate this as a percentage of total number of interested participants.
|
5month recruitment period
|
|
Recruitment and retention: Response rate
Time Frame: 5month recruitment period
|
Calculate the total number of eligible participants who went onto complete the consent form.
Calculate this as a percentage of total number of eligible participants.
|
5month recruitment period
|
|
Recruitment and retention: One month follow up retention rates
Time Frame: Baseline plus 1 months (28 days), end of trial period
|
Calculate the total number of participants enrolled onto the study who went onto complete the 1month follow up.
Calculate this as a percentage of total number of enrolled participants.
|
Baseline plus 1 months (28 days), end of trial period
|
|
Recruitment and retention 4: Three month follow up retention rates
Time Frame: Baseline plus 3 months (84 days)
|
Calculate the total number of participants enrolled onto the study who went onto complete the 3month follow up.
Calculate this as a percentage of total number of enrolled participants.
|
Baseline plus 3 months (84 days)
|
|
Recruitment and retention 5: Comparability of sample to MOD personnel
Time Frame: Baseline plus 3 months (84 days)
|
Comparability of sample to Ministry of Defence statistics for major sub-groups of veterans (age, service branch, rank)
|
Baseline plus 3 months (84 days)
|
|
Trial procedures and outcome measures: Technical delivery
Time Frame: Baseline plus 1 months (28 days), end of trial period
|
Evaluation of the technical delivery of the app was gained through gathering feedback from developers and participants, identifying any potential technical issues
|
Baseline plus 1 months (28 days), end of trial period
|
|
Trial procedures and outcome measures: GHQ12
Time Frame: Baseline plus 3 months (84 days)
|
The General Health Questionnaire (GHQ-12) is a measure of common mental disorders such as anxiety and depression.
It is a 12-item self-report questionnaire measured on a 4-point scale.
Scores range from 0-12 with a score of 4 or more indicative of probable mental ill health.The difference between scores at baseline, day 28 (1month) and day 84 (3months) were calculated.
|
Baseline plus 3 months (84 days)
|
|
Trial procedures and outcome measures: PCL-C
Time Frame: Baseline plus 3 months (84 days)
|
To evaluate symptoms of PTSD, the PTSD Checklist Civilian version (PCL-C) was used.
It is a 17-item self-report questionnaire, measured on a 5-point scale from (1) not at all to (5) extremely.
Scores range from 17 to 85, scores over 50 are indicative of possible PTSD.
The difference between scores at baseline, day 28 (1month) and day 84 (3months) were calculated.
|
Baseline plus 3 months (84 days)
|
|
Trial procedures and outcome measures: Well-being
Time Frame: Baseline plus 3 months (84 days)
|
Warwick Edinburgh Mental Well-being Scale (WEMWBS) measures mental well-being within the previous two weeks and is a 14-item self-report questionnaire measured on a 5-point scale from (1) none of the time to (5) all of the time.
Scores range from 14 to 70 with higher scores indicative of greater mental well being.
The difference between scores at baseline, day 28 (1month) and day 84 (3months) were calculated.
|
Baseline plus 3 months (84 days)
|
|
Trial procedures and outcome measures: WHO QOL-BREF
Time Frame: Baseline plus 3 months (84 days)
|
Quality of life was assessed using the World Health Organization Quality of Life Assessment (WHOQOL-BREF), a 26-item self-report questionnaire divided into four domains: physical health; social relationships; psychological health; environmental health.
It is measured on a 5-point scale, with a score of 0-100 calculated, where 100 equates to the best possible state of health.
The difference between scores at baseline, day 28 (1month) and day 84 (3months) were calculated.
|
Baseline plus 3 months (84 days)
|
|
Trial procedures and outcome measures: Completion rates
Time Frame: Baseline plus 3 months (84 days)
|
Examination of the feasibility of using the app to collection outcome measures was assessed via completion rates for each of the questionnaires (baseline; 1month follow up; 3month follow up)
|
Baseline plus 3 months (84 days)
|
|
Trial procedures and outcome measures: Sample size
Time Frame: Baseline plus 3 months (84 days)
|
Sample size estimates for a future randomised control trial were assessed via changes in GHQ12 scores from baseline to 3month follow up.
|
Baseline plus 3 months (84 days)
|
|
Acceptability and usability: Usage
Time Frame: Baseline plus 1 month (28 days), end of initial trial period
|
App usage data were collected from Google Analytics via Firebase (CA, USA) and included information such as the number of times the app was opened, the duration of each app use and the number of times specific sections of the app were used.
|
Baseline plus 1 month (28 days), end of initial trial period
|
|
Acceptability and usability: MAUQ
Time Frame: Baseline plus 1 month (28 days), end of initial trial period
|
The mHealth App Usability Questionnaire (MAUQ) was used to assess app usability at day 28.
A 16 item version of the MAUQ of the self-report questionnaire was used, measured on a 7-point scale ranging from strongly disagree (1) to strongly agree (7).
Participant responses were aggregated into overall usability and three other domains: ease of use and satisfaction, interface and functionality, and usefulness.
The mean total score and the mean of each three domains were scored out of seven, with a score of four indicating a neutral response and higher scores indicating greater app usability.
|
Baseline plus 1 month (28 days), end of initial trial period
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nicola Fear, Prof, King's College London
- Principal Investigator: Sharon Stevelink, PhD, King's College London
- Principal Investigator: Neil Greenberg, Prof, King's College London
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 583696
- DPRF-19/20-11079 (Other Identifier: King's College London)
- 1074/MODREC/20 (Other Identifier: MODREC)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Health Wellness 1
-
Indiana UniversityCommunity Health Network; Boys & Girls Clubs of IndianapolisCompletedMental Health Wellness 1 | Child Behavior | Adolescent Behavior | Mental Health Wellness 2United States
-
Cedars-Sinai Medical CenterNot yet recruitingMental Health Wellness 1 | Wellness, PsychologicalUnited States
-
Universiti Putra MalaysiaGreen International UniversityNot yet recruitingMental Health Wellness 1
-
Northern Arizona UniversityUniversity of Colorado, DenverRecruiting
-
The New SchoolColumbia University; Universidad del Norte; HIASRecruitingMental Health Wellness 1Colombia
-
University of Wisconsin, MadisonCompletedMental Health Wellness 1United States
-
University of BathKing's College London; University of Pennsylvania; Newcastle University; University... and other collaboratorsCompletedMental Health Wellness 1United Kingdom
-
The University of Hong KongThe Boys' and Girls' Clubs Association of Hong KongCompleted
-
University of South WalesMIND CymruTerminated
-
NYU Silver School of Social WorkCompletedMental Health Wellness 1United States
Clinical Trials on MeT4VeT mobile phone app: control
-
National Institute of Allergy and Infectious Diseases...Clinical Trials in Organ Transplantation in ChildrenCompletedPediatric Heart Transplantation | Pediatric Heart Transplant Recipients | Pediatric Cardiac TransplantationUnited States
-
The University of Texas Health Science Center at...Completed
-
University of CambridgeCompletedHydrocephalus in InfantsUnited Kingdom
-
Defense and Veterans Center for Integrative Pain...Completed
-
Zhongshan People's Hospital, Guangdong, ChinaRecruitingPostoperative Complications | Telerehabilitation | Patient Reported Outcome Measures | Exercise Therapy | Lung Neoplasms, Non-Small Cell Lung CancerChina
-
Vanderbilt University Medical CenterNational Institute of Mental Health (NIMH)RecruitingEngagement, Patient | Parental Anxiety | Length of Stay | Usability | Self-Efficacy | Postpartum Depression (PPD)United States
-
University of MichiganWashington University School of Medicine; National Institute of Nursing Research...Completed
-
Gillian GreshamCompletedMelanoma | Sarcoma | Neoplasms | Lymphoma | Kidney Cancer | Leukemia | Cancer | Breast Cancer | Head and Neck Cancer | Gynecologic Cancer | Glioblastoma | Multiple Myeloma | Stress | Colorectal Cancer | Anxiety | Lung Cancer | Prostate Cancer | Bladder Cancer | Loneliness | Pancreas Cancer | Cancer Metastatic | Uterine Cancer | Social IsolationUnited States
-
Pontificia Universidad Catolica de ChileCompletedSmoking CessationChile
-
Emory UniversityNational Institute of Mental Health (NIMH); Kenya Medical Research InstituteSuspended